In a report released today, Andrew Semple from Echelon Wealth Partners reiterated a Buy rating on Trulieve Cannabis (TCNNF - Research Report), with a price target of C$45.00. The company's shares closed today at $12.92.Semple covers the Basic Materials sector, focusing on stocks such as Vext Science, Trulieve Cannabis, and Indiva. According to TipRanks, Semple has an average return of -1.2% and a 23.33% success rate on recommended stocks. Trulieve Cannabis has an analyst consensus of Strong Buy, with a price target consensus of $37.14, implying a 187.46% upside from current levels.
https://www.tipranks.com/news/blurbs/echelon-wealth-partners-sticks-to-their-buy-rating-for-trulieve-cannabis-tcnnf?utm_source=advfn.com&utm_medium=referral
Trulieve Cannabis (QX) (USOTC:TCNNF)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more Trulieve Cannabis (QX) Charts.
Trulieve Cannabis (QX) (USOTC:TCNNF)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Trulieve Cannabis (QX) Charts.